CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR

CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2022-08
Hauptverfasser: Calza, Leonardo, Bon, Isabella, Pensalfine, Giulia, Vitale, Salvatore, Appolloni, Lucia, Viale, Pierluigi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Journal of acquired immune deficiency syndromes (1999)
container_volume
creator Calza, Leonardo
Bon, Isabella
Pensalfine, Giulia
Vitale, Salvatore
Appolloni, Lucia
Viale, Pierluigi
description
doi_str_mv 10.1097/QAI.0000000000003077
format Article
fullrecord <record><control><sourceid>wolterskluwer</sourceid><recordid>TN_cdi_wolterskluwer_health_00126334-990000000-00095</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00126334-990000000-00095</sourcerecordid><originalsourceid>FETCH-wolterskluwer_health_00126334-990000000-000953</originalsourceid><addsrcrecordid>eNqdkM1qg1AQhe-ihaY_b9DFfYEbNWrE5UTHOFSv6TgKWYUsLKEVCjElj9VX7G1JoesODHPgzHdgRqnHwJ8Hfpp4z0Bz_0-FfpJcqVkQL2ITBWF8o26n6dX3g2UUpTP1mZVg19hqsrpF7monigrqGqThra6Bn5B_XLBCjMJNTwyVlhIZNltjgXrUJfXGgZgJ5noDQmil1a0AC9m1zpuqE1wzONZz6dR3OVnUDWtB2xTfmRoqKNA6M0cPa2HKSGDl1rwVZb_0vbp-2Y_T8HCZdyoqULLSnN_H03Cc3saP83DcHYb9eDrs3JmLZRhGJk0v7zCu0zj8J_YF4uJfHg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR</title><source>Journals@Ovid LWW Legacy Archive</source><source>Free E- Journals</source><creator>Calza, Leonardo ; Bon, Isabella ; Pensalfine, Giulia ; Vitale, Salvatore ; Appolloni, Lucia ; Viale, Pierluigi</creator><creatorcontrib>Calza, Leonardo ; Bon, Isabella ; Pensalfine, Giulia ; Vitale, Salvatore ; Appolloni, Lucia ; Viale, Pierluigi</creatorcontrib><identifier>ISSN: 1525-4135</identifier><identifier>DOI: 10.1097/QAI.0000000000003077</identifier><language>eng</language><publisher>JAIDS Journal of Acquired Immune Deficiency Syndromes</publisher><ispartof>Journal of acquired immune deficiency syndromes (1999), 2022-08</ispartof><rights>JAIDS Journal of Acquired Immune Deficiency Syndromes</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00126334-990000000-00095$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00126334-990000000-00095$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids></links><search><creatorcontrib>Calza, Leonardo</creatorcontrib><creatorcontrib>Bon, Isabella</creatorcontrib><creatorcontrib>Pensalfine, Giulia</creatorcontrib><creatorcontrib>Vitale, Salvatore</creatorcontrib><creatorcontrib>Appolloni, Lucia</creatorcontrib><creatorcontrib>Viale, Pierluigi</creatorcontrib><title>CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR</title><title>Journal of acquired immune deficiency syndromes (1999)</title><issn>1525-4135</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqdkM1qg1AQhe-ihaY_b9DFfYEbNWrE5UTHOFSv6TgKWYUsLKEVCjElj9VX7G1JoesODHPgzHdgRqnHwJ8Hfpp4z0Bz_0-FfpJcqVkQL2ITBWF8o26n6dX3g2UUpTP1mZVg19hqsrpF7monigrqGqThra6Bn5B_XLBCjMJNTwyVlhIZNltjgXrUJfXGgZgJ5noDQmil1a0AC9m1zpuqE1wzONZz6dR3OVnUDWtB2xTfmRoqKNA6M0cPa2HKSGDl1rwVZb_0vbp-2Y_T8HCZdyoqULLSnN_H03Cc3saP83DcHYb9eDrs3JmLZRhGJk0v7zCu0zj8J_YF4uJfHg</recordid><startdate>20220818</startdate><enddate>20220818</enddate><creator>Calza, Leonardo</creator><creator>Bon, Isabella</creator><creator>Pensalfine, Giulia</creator><creator>Vitale, Salvatore</creator><creator>Appolloni, Lucia</creator><creator>Viale, Pierluigi</creator><general>JAIDS Journal of Acquired Immune Deficiency Syndromes</general><scope/></search><sort><creationdate>20220818</creationdate><title>CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR</title><author>Calza, Leonardo ; Bon, Isabella ; Pensalfine, Giulia ; Vitale, Salvatore ; Appolloni, Lucia ; Viale, Pierluigi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-wolterskluwer_health_00126334-990000000-000953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Calza, Leonardo</creatorcontrib><creatorcontrib>Bon, Isabella</creatorcontrib><creatorcontrib>Pensalfine, Giulia</creatorcontrib><creatorcontrib>Vitale, Salvatore</creatorcontrib><creatorcontrib>Appolloni, Lucia</creatorcontrib><creatorcontrib>Viale, Pierluigi</creatorcontrib><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Calza, Leonardo</au><au>Bon, Isabella</au><au>Pensalfine, Giulia</au><au>Vitale, Salvatore</au><au>Appolloni, Lucia</au><au>Viale, Pierluigi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><date>2022-08-18</date><risdate>2022</risdate><issn>1525-4135</issn><pub>JAIDS Journal of Acquired Immune Deficiency Syndromes</pub><doi>10.1097/QAI.0000000000003077</doi></addata></record>
fulltext fulltext
identifier ISSN: 1525-4135
ispartof Journal of acquired immune deficiency syndromes (1999), 2022-08
issn 1525-4135
language eng
recordid cdi_wolterskluwer_health_00126334-990000000-00095
source Journals@Ovid LWW Legacy Archive; Free E- Journals
title CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T05%3A19%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CHANGES%20IN%20SERUM%20INFLAMMATORY%20MARKERS%20IN%20ANTIRETROVIRAL%20THERAPY-NAIVE%20HIV-INFECTED%20PATIENTS%20STARTING%20DOLUTEGRAVIR/LAMIVUDINE%20OR%20TENOFOVIR%20ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Calza,%20Leonardo&rft.date=2022-08-18&rft.issn=1525-4135&rft_id=info:doi/10.1097/QAI.0000000000003077&rft_dat=%3Cwolterskluwer%3E00126334-990000000-00095%3C/wolterskluwer%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true